Strengthening Families & Communities LLC Has $3.06 Million Stake in Synopsys, Inc. $SNPS

Strengthening Families & Communities LLC grew its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 3,105.7% in the third quarter, Holdings Channel reports. The institutional investor owned 6,187 shares of the semiconductor company’s stock after purchasing an additional 5,994 shares during the period. Strengthening Families & Communities LLC’s holdings in Synopsys were worth $3,057,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. Stanley Laman Group Ltd. increased its stake in shares of Synopsys by 542.9% in the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after buying an additional 10,874 shares during the period. Symphony Financial Ltd. Co. lifted its stake in shares of Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares during the period. Bank of New York Mellon Corp boosted its holdings in Synopsys by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after acquiring an additional 4,815 shares during the last quarter. Waverton Investment Management Ltd increased its position in Synopsys by 15.0% in the second quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock worth $296,630,000 after purchasing an additional 75,374 shares during the period. Finally, Angeles Wealth Management LLC bought a new stake in Synopsys during the 2nd quarter worth about $478,000. Institutional investors own 85.47% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on SNPS. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and reduced their target price for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Needham & Company LLC increased their price objective on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. Morgan Stanley increased their price target on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Finally, JPMorgan Chase & Co. raised their price target on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Synopsys has a consensus rating of “Moderate Buy” and a consensus price target of $553.57.

Insider Buying and Selling

In other Synopsys news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 4,157 shares of company stock valued at $1,945,036. 0.62% of the stock is owned by company insiders.

Synopsys Price Performance

SNPS opened at $457.89 on Tuesday. The stock has a market cap of $87.60 billion, a P/E ratio of 57.31, a P/E/G ratio of 3.87 and a beta of 1.12. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The company has a fifty day simple moving average of $478.60 and a 200 day simple moving average of $500.20.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company’s revenue was up 37.8% on a year-over-year basis. During the same period in the previous year, the firm earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.